You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 23, 2024

Litigation Details for Pharmacyclics LLC v. Alvogen Pine Brook LLC (D. Del. 2019)


✉ Email this page to a colleague

« Back to Dashboard


Pharmacyclics LLC v. Alvogen Pine Brook LLC (D. Del. 2019)

Docket ⤷  Sign Up Date Filed 2019-03-01
Court District Court, D. Delaware Date Terminated 2021-08-30
Cause 35:271 Patent Infringement Assigned To Colm Felix Connolly
Jury Demand Defendant Referred To Christopher J. Burke
Parties PHARMACYCLICS LLC
Patents 10,004,746; 10,010,507; 10,016,435; 10,106,548; 10,125,140; 10,213,386; 10,294,231; 10,294,232; 6,346,532; 7,342,117; 7,514,444; 7,879,828; 7,982,049; 8,008,309; 8,101,659; 8,476,284; 8,497,277; 8,563,563; 8,697,711; 8,703,780; 8,735,403; 8,754,090; 8,754,091; 8,796,331; 8,877,938; 8,952,015; 8,957,079; 8,999,999; 9,125,889; 9,181,257; 9,296,753; 9,388,134; 9,540,382; 9,655,857; 9,713,617; 9,725,455; 9,795,604; 9,801,881; 9,801,883; 9,814,721
Attorneys Hannah Lee
Firms Young, Conaway, Stargatt & Taylor LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Pharmacyclics LLC v. Alvogen Pine Brook LLC
The small molecule drugs covered by the patents cited in this case are ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , ⤷  Sign Up , and ⤷  Sign Up .
Biologic Drugs cited in Pharmacyclics LLC v. Alvogen Pine Brook LLC

The biologic drugs covered by the patents cited in this case are ⤷  Sign Up , ⤷  Sign Up , and ⤷  Sign Up .

Details for Pharmacyclics LLC v. Alvogen Pine Brook LLC (D. Del. 2019)

Date Filed Document No. Description Snippet Link To Document
2022-10-18 Infringement of Certain Elements of U.S. Patent Nos. 8,877,938 and 9,388,134. Signed by Judge Richard G…2019 30 August 2021 1:19-cv-00434 835 Patent - Abbreviated New Drug Application(ANDA) Defendant External link to document
2019-03-01 1 Complaint PageID #: 2 Patent”); 9,655,857 (“the ’857 Patent”); 9,725,455 (“the ’455 Patent”); 10,010,507 (“the ’507… United States Patent Nos. 7,514,444 (“the ’444 Patent”); 8,008,309 (“the ’309 Patent”); 8,476,284 (“…(“the ’284 Patent”); 8,497,277 (“the ’277 Patent”); 8,697,711 (“the ’711 Patent”); 8,735,403 (“the ’403…’403 Patent”); 8,754,090 (“the ’090 Patent”); 8,754,091 (“the ’091 Patent”); 8,952,015 (“the ’015 Patent…507 Patent”); 10,106,548 (“the ’548 Patent”); and 10,125,140 (“the ’140 Patent”). External link to document
2023-07-21 1120 FINAL JUDGMENT Regarding U.S. Patent No. 8,101,659 (see Judgment for further details). Signed by…2019 30 August 2021 1:19-cv-00434 835 Patent - Abbreviated New Drug Application(ANDA) Defendant External link to document
2023-08-04 1137 Invalidity Contentions for U.S. Patent Nos.11,058,667 and 8,101,659 filed by Nanjing Noratech Pharmaceutical…2019 30 August 2021 1:19-cv-00434 835 Patent - Abbreviated New Drug Application(ANDA) Defendant External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.